| 规格 | 价格 | |
|---|---|---|
| 100uL/well | ||
| 20uL/well |
| 参考文献 |
[1]. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci Rep. 2020 Aug 4;10(1):13093.
[2]. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat Med. 2017 Apr 7; 23(4): 405–408. |
|---|
| 外观&性状 |
Typically exists as solids (or liquids in special cases) at room temperature
|
|---|---|
| HS Tariff Code |
2934.99.9001
|
| 溶解度 (体外实验) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|
计算结果:
工作液浓度: mg/mL;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL)。如该浓度超过该批次药物DMSO溶解度,请首先与我们联系。
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
(1) 请确保溶液澄清之后,再加入下一种溶剂 (助溶剂) 。可利用涡旋、超声或水浴加热等方法助溶;
(2) 一定要按顺序加入溶剂 (助溶剂) 。